What does OGS mean in COMPANIES & FIRMS
Oxford GlycoSciences, P.L.C., or commonly referred to as OGS, is a world-leading biotechnology company focusing on the research and development of diagnostic and therapeutic products for diseases with an underlying metabolic abnormality. OGS has developed numerous groundbreaking technologies such as carbohydrate microarrays, glycoproteomics and theragnostics that have transformed the field of glycomics. Through its industry-leading research, OGS has become a driving force in the advancement of precision medicine and personalized healthcare treatments.
OGS meaning in Companies & Firms in Business
OGS mostly used in an acronym Companies & Firms in Category Business that means Oxford GlycoSciences, P. L. C.
Shorthand: OGS,
Full Form: Oxford GlycoSciences, P. L. C.
For more information of "Oxford GlycoSciences, P. L. C.", see the section below.
What Does OGS Mean?
OGS stands for Oxford GlycoSciences, P. L. C., which is a biotechnology company located in Oxfordshire, England. OGS was founded in 1988 and since then it has been dedicated to developing innovative medical technology that can help diagnose and treat metabolic diseases. The company focuses on using glycological techniques such as carbohydrate microarrays, glycoproteomics and theragnostics to develop new products that can improve patient caregiving experiences. Furthermore, through its extensive research efforts, OGS contributes drastically to the advancement of precision medicine worldwide.
Essential Questions and Answers on Oxford GlycoSciences, P. L. C. in "BUSINESS»FIRMS"
What is Oxford GlycoSciences, P. L. C.?
Oxford GlycoSciences, P. L. C. is a biopharmaceutical company dedicated to developing and commercializing innovative drug therapies for the treatment of cancer and other diseases related to glycosylation deficiencies. They specialize in researching new treatments for inherited metabolic disorders such as alpha-1 antitrypsin deficiency (AATD).
What type of treatments does Oxford GlycoSciences, P. L. C research?
Oxford GlycoSciences, P. L. C researches therapeutic treatments that are tailored specifically for each individual’s genetic makeup and metabolic needs, with an emphasis on treating cancer and other diseases related to glycosylation deficiencies.
How long has Oxford GlycoSciences, P. L. C been in operation?
The company has been in operation since 1997 and has become one of the leading research organizations in the world when it comes to creating innovative treatments for cancers and metabolic disorders related to glycosylation deficiencies
What products are offered by Oxford GlycoSciences, P. L. C.?
Oxford GlycoSciences, P. L. C provides a range of products designed to treat cancer or other diseases related to glycosylation deficiencies, including efalizumab (Raptiva®, Efatec®), rhuMAb EGFR (Erbitux®) and rhuMAb HER2/neu (Herceptin®).
What is efalizumab used for?
Efalizumab (known commercially as Raptiva® or Efatec®) is an immunomodulatory monoclonal antibody which is approved by regulators around the world for the treatment of adult patients with moderate-to-severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy.
What is rhuMAb EGFR used for?
RhuMAb EGFR (known commercially as Erbitux®) is a recombinant humanized monoclonal antibody which binds specifically to epidermal growth factor receptor (EGFR) on tumor cells, thereby blocking their stimulation by EGFR ligands.
What is rhuMAb HER2/neu used for?
RhuMAb HER2/neu (known commercially as Herceptin®) is a recombinant humanized monoclonal antibody designed particularly to target HER2/neu positive tumors as well as breast cancer invasive lobular carcinoma.
Is there any additional information available about Oxford GlycoSciences, P. L.C.?
Yes! Additional information can be found on their website including product information sheets, clinical trial updates and more!
Does Oxford GlycoSciences have any partnerships or collaborations with other companies?
Yes! The company partners with many different organizations such as pharma companies, academic institutions etc., in order to help advance their research into innovative drugs therapies for cancers and other diseases related to glycosylation deficiencies.
Final Words:
In summary, OGS stands for Oxford GlycoSciences, P. L. C., a leading biotechnology company in the UK that specializes in developing innovative medical products and services through advanced glycomics-based technologies for diagnosing and treating metabolic disorders. Through its research activities, OGS pushes forward the horizon of precision medicine which helps bring more accurate diagnosis and treatment closer to reality for those suffering from metabolic diseases around the world.
OGS also stands for: |
|
| All stands for OGS |